Lv6
2180 积分 2024-10-11 加入
Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint
9天前
已完结
Pathologic Response of HER2-positive Gastric Cancer to Trastuzumab-based Chemotherapy
11天前
已完结
Tumour regression grade (TRG) analyses in patients with resectable gastro‐oesophageal adenocarcinomas treated with platinum‐based neoadjuvant chemotherapy
11天前
已完结
Determination of the optimal cutoff percentage of residual tumors to define the pathological response rate for gastric cancer treated with preoperative therapy (JCOG1004-A)
11天前
已完结
Excellent Interobserver Agreement on Grading the Extent of Residual Carcinoma After Preoperative Chemoradiation in Esophageal and Esophagogastric Junction Carcinoma: A Reliable Predictor for Patient Outcome
11天前
已完结
Rectal cancer staging post neoadjuvant therapy--how should the changes be assessed?
11天前
已完结
Pathological response following long‐course neoadjuvant chemoradiotherapy for locally advanced rectal cancer
11天前
已完结
Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial
11天前
已完结
Perioperative approaches for patients with biliary tract cancer
23天前
已完结
Histopathological changes after microwave coagulation therapy for patients with hepatocellular carcinoma: review of 15 explanted livers
27天前
已完结
皖公网安备34019202002308
